相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Toll-like receptors and chronic inflammation in rheumatic diseases: new developments
Leo A. B. Joosten et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology
Simona Frosali et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells
Katherine H. Parker et al.
CANCER RESEARCH (2014)
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
Domenica Musumeci et al.
PHARMACOLOGY & THERAPEUTICS (2014)
The two faces of IL-6 in the tumor microenvironment
Daniel T. Fisher et al.
SEMINARS IN IMMUNOLOGY (2014)
Next-generation peptide vaccines for advanced cancer
Akira Yamada et al.
CANCER SCIENCE (2013)
The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
John P. Vasilakos et al.
EXPERT REVIEW OF VACCINES (2013)
Role of toll-like receptors in systemic sclerosis
Marzena Ciechomska et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2013)
Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving anticancer vaccination strategies
Constantin N. Baxevanis et al.
IMMUNOTHERAPY (2013)
Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination
Nao Jounai et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
HMGB1: the central cytokine for all lymphoid cells
Guanqiao Li et al.
FRONTIERS IN IMMUNOLOGY (2013)
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
Michelle K. Gleason et al.
BLOOD (2012)
Tim-3, a negative regulator of anti-tumor immunity
Ana Carrizosa Anderson
CURRENT OPINION IN IMMUNOLOGY (2012)
Tumor immunity times out: TIM-3 and HMGB1
Daolin Tang et al.
NATURE IMMUNOLOGY (2012)
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
Shigeki Chiba et al.
NATURE IMMUNOLOGY (2012)
Recent advances in herbal medicine for treatment of liver diseases
Nilanjan Ghosh et al.
PHARMACEUTICAL BIOLOGY (2011)
TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
Y. Wu et al.
BRITISH JOURNAL OF CANCER (2010)
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
Ying Ju et al.
JOURNAL OF HEPATOLOGY (2010)
The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
Kellie A. Charles et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C. Anderson et al.
SCIENCE (2007)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Jane Tian et al.
NATURE IMMUNOLOGY (2007)
Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities
Luca Mollica et al.
CHEMISTRY & BIOLOGY (2007)
Cyclooxygenase-2 inhibition promotes enhancement of antitumor responses by transcutaneous vaccination with cytosine-phosphate-guanosine-oligodeoxynucleotides and model tumor antigen
Joe Inoue et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: Role of IDO
Gargi D Basu et al.
JOURNAL OF IMMUNOLOGY (2006)
Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
IE Dumitriu et al.
JOURNAL OF IMMUNOLOGY (2005)
Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review
JT Coon et al.
JOURNAL OF HEPATOLOGY (2004)
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
